PolyNovo Limited (ASX:PNV)
Australia · Delayed Price · Currency is AUD 1.040
+0.010 (0.97%)
Aug 28, 2026, 4:10 PM AEST
PolyNovo Market Cap
PolyNovo has a market cap or net worth of 718.48 million as of August 28, 2026. Its market cap has decreased by -22.68% in one year.
Market Cap
718.48M
Enterprise Value
700.62M
Revenue
149.85M
Ranking
n/a
PE Ratio
99.05
Stock Price
1.04
ChartMarket Cap Chart
Since August 23, 1999, PolyNovo's market cap has increased from 33.09M to 718.48M, an increase of 2,071.47%. That is a compound annual growth rate of 12.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 718.48M | -15.45% |
| Dec 31, 2025 | 849.74M | -39.71% |
| Dec 31, 2024 | 1.41B | 23.37% |
| Dec 29, 2023 | 1.14B | -17.80% |
| Dec 30, 2022 | 1.39B | 37.79% |
| Dec 31, 2021 | 1.01B | -60.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cochlear | 9.01B |
| 4DMedical | 2.28B |
| Imricor Medical Systems | 695.63M |
| EBR Systems | 222.24M |
| Aroa Biosurgery | 193.71M |
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 156.25M |
| Lumos Diagnostics Holdings | 99.16M |